ecteinascidin 743 has been researched along with indazoles in 14 studies
| Studies (ecteinascidin 743) | Trials (ecteinascidin 743) | Recent Studies (post-2010) (ecteinascidin 743) | Studies (indazoles) | Trials (indazoles) | Recent Studies (post-2010) (indazoles) |
|---|---|---|---|---|---|
| 660 | 102 | 404 | 5,609 | 550 | 3,265 |
| Protein | Taxonomy | ecteinascidin 743 (IC50) | indazoles (IC50) |
|---|---|---|---|
| Chain A, Cell Division Protein Kinase 2 | Homo sapiens (human) | 185 | |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
| Chain A, Cell Division Protein Kinase 2 | Homo sapiens (human) | 185 | |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | Homo sapiens (human) | 185 | |
| Chain A, Cell Division Protein Kinase 2 | Homo sapiens (human) | 185 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (85.71) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Manson, SC; Penel, N; Powell, S; Sharma, S; Takyar, S | 1 |
| Cornillie, J; Hompes, D; Li, H; Schöffski, P; Wozniak, A | 1 |
| Cuesta, M; Guix, M; Hernández-Pastor, LJ; Lavernia, J; Villa, G | 1 |
| Carbini, M; Maki, RG; Pang, A | 1 |
| Azvolinsky, A | 1 |
| Fader, AN; Ricci, S; Stone, RL | 1 |
| Araki, N; Kawai, A; Takahashi, S; Ueda, T; Yonemori, K | 1 |
| Blay, JY; Boye, K; Brahmi, M; Casali, PG; Duffaud, F; Fedenko, A; Gelderblom, H; Hindi, N; Italiano, A; Kawai, A; Kobayashi, E; Kosela, H; Le Cesne, A; Maki, RG; Martin-Broto, J; Mir, O; Patel, S; Provenzano, S; Rutkowski, P; Somaiah, N; Stacchiotti, S; Sundby Hall, K; Vincenzi, B | 1 |
| Sleijfer, S; Vos, M | 1 |
| Desar, IME; Fleuren, EDG; van der Graaf, WTA | 1 |
| Hayashi, K; Igarashi, K; Miwa, S; Takeuchi, A; Tsuchiya, H; Yamamoto, N | 1 |
| Blay, JY | 1 |
| Asanuma, K; Hagi, T; Nakamura, T; Sudo, A | 1 |
| Caldari, E; De Paolis, M; Fiore, M; Giannini, C; Pirini, MG; Sambri, A; Spinnato, P; Zucchini, R | 1 |
9 review(s) available for ecteinascidin 743 and indazoles
| Article | Year |
|---|---|
Efficacy and safety of pharmacological interventions in second- or later-line treatment of patients with advanced soft tissue sarcoma: a systematic review.
Topics: Antineoplastic Agents; Dacarbazine; Deoxycytidine; Dioxoles; Gemcitabine; Humans; Indazoles; Pyrimidines; Randomized Controlled Trials as Topic; Sarcoma; Sulfonamides; Tetrahydroisoquinolines; Trabectedin; Treatment Failure | 2013 |
Soft tissue sarcoma: an update on systemic treatment options for patients with advanced disease.
Topics: Antineoplastic Agents; Dioxoles; Doxorubicin; Evidence-Based Medicine; Humans; Ifosfamide; Indazoles; Pyrimidines; Sarcoma; Sulfonamides; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome | 2014 |
Contemporary Therapy for Advanced Soft-Tissue Sarcomas in Adults: A Review.
Topics: Adult; Antineoplastic Agents; Dioxoles; Furans; Humans; Indazoles; Ketones; Pyrimidines; Randomized Controlled Trials as Topic; Sarcoma; Sulfonamides; Tetrahydroisoquinolines; Trabectedin; Tumor Microenvironment | 2016 |
Uterine leiomyosarcoma: Epidemiology, contemporary treatment strategies and the impact of uterine morcellation.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Chemotherapy, Adjuvant; Deoxycytidine; Diagnostic Errors; Dioxoles; Docetaxel; Doxorubicin; Female; Gemcitabine; Humans; Hysterectomy; Indazoles; Laparoscopy; Leiomyoma; Leiomyosarcoma; Morcellation; Neoplasm Staging; Pyrimidines; Sulfonamides; Taxoids; Tetrahydroisoquinolines; Trabectedin; Uterine Myomectomy; Uterine Neoplasms | 2017 |
Systemic Therapy for Soft Tissue Sarcoma: Proposals for the Optimal Use of Pazopanib, Trabectedin, and Eribulin.
Topics: Antineoplastic Agents, Alkylating; Dioxoles; Furans; Humans; Indazoles; Japan; Ketones; Pyrimidines; Sarcoma; Sulfonamides; Tetrahydroisoquinolines; Trabectedin | 2017 |
EJC's biennial report on metastatic soft tissue sarcoma: State of the art and future perspectives.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Dioxoles; Doxorubicin; Drug Therapy; Forecasting; Humans; Indazoles; Neoplasm Metastasis; Pyrimidines; Sarcoma; Sulfonamides; Tetrahydroisoquinolines; Trabectedin | 2018 |
Systemic Treatment for Adults with Synovial Sarcoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Humans; Ifosfamide; Indazoles; Pyrimidines; Sarcoma, Synovial; Sulfonamides; Trabectedin | 2018 |
Therapeutic Targets for Bone and Soft-Tissue Sarcomas.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bone Neoplasms; Drug Therapy; Furans; Humans; Immunotherapy, Adoptive; Indazoles; Ipilimumab; Ketones; Nivolumab; Osteosarcoma; Progression-Free Survival; Pyrimidines; Sarcoma; Soft Tissue Neoplasms; Sorafenib; Sulfonamides; Trabectedin | 2019 |
The Biology of Synovial Sarcoma: State-of-the-Art and Future Perspectives.
Topics: Anthracyclines; Antineoplastic Agents; Chemotherapy, Adjuvant; Epigenomics; Gene Expression Regulation, Neoplastic; Genomics; Humans; Ifosfamide; Indazoles; Molecular Targeted Therapy; Pyrimidines; Radiotherapy, Adjuvant; Sarcoma, Synovial; Soft Tissue Neoplasms; Sulfonamides; Surgical Procedures, Operative; Trabectedin | 2021 |
5 other study(ies) available for ecteinascidin 743 and indazoles
| Article | Year |
|---|---|
Cost-effectiveness analysis of pazopanib in second-line treatment of advanced soft tissue sarcoma in Spain.
Topics: Antineoplastic Agents; Clinical Trials, Phase III as Topic; Cost-Benefit Analysis; Dioxoles; Disease Progression; Drug Costs; Humans; Indazoles; Probability; Pyrimidines; Quality-Adjusted Life Years; Sarcoma; Spain; Sulfonamides; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome | 2015 |
Heterogeneous and Rare: Toward Histology-Specific Treatment of Soft-Tissue Sarcoma.
Topics: Antineoplastic Agents; Chromosomal Proteins, Non-Histone; Dioxoles; Disease-Free Survival; DNA-Binding Proteins; Furans; Humans; Indazoles; Ketones; Molecular Targeted Therapy; Mutation; Pyrimidines; Sarcoma; SMARCB1 Protein; Sulfonamides; Tetrahydroisoquinolines; Trabectedin; Transcription Factors | 2016 |
Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Follow-Up Studies; Humans; Indazoles; Male; Middle Aged; Prognosis; Pyrimidines; Retrospective Studies; Sarcoma, Alveolar Soft Part; Sulfonamides; Survival Rate; Trabectedin | 2018 |
Treatment of advanced soft tissue sarcoma by histological subtype: wish, prediction or reality?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Deoxycytidine; Doxorubicin; Female; Furans; Gemcitabine; Humans; Ifosfamide; Indazoles; Ketones; Liposarcoma; Middle Aged; Prognosis; Pyrimidines; Sulfonamides; Survival Rate; Trabectedin | 2019 |
Clinical Outcome of Systemic Treatment for Advanced Soft Tissue Sarcoma: Real-Life Perspective in Japan.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Female; Furans; Humans; Indazoles; Japan; Kaplan-Meier Estimate; Ketones; Male; Middle Aged; Neoplasm Metastasis; Prognosis; Pyrimidines; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Sulfonamides; Survival Analysis; Trabectedin; Treatment Outcome | 2020 |